Health Care & Life Sciences » Pharmaceuticals | Humanwell Healthcare

Humanwell Healthcare | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
6,008
7,048
10,051
12,231
15,303
18,488
Cost of Goods Sold (COGS) incl. D&A
3,573
4,203
6,491
7,925
9,796
11,509
Gross Income
2,435
2,845
3,560
4,306
5,508
6,980
SG&A Expense
1,479
1,831
2,380
2,825
3,938
5,173
EBIT
893
938
1,084
1,463
1,564
1,799
Unusual Expense
-
-
-
87
185
3,071
Non Operating Income/Expense
26
5
64
164
1,669
446
Interest Expense
168
209
277
392
585
777
Pretax Income
760
795
965
1,309
2,912
1,486
Income Tax
169
186
219
285
628
484
Equity in Affiliates
10
27
107
56
35
9
Consolidated Net Income
601
636
853
1,080
2,318
1,961
Net Income
418
452
654
832
2,069
2,358
Net Income After Extraordinaries
418
452
654
832
2,069
2,358
Net Income Available to Common
418
452
654
832
2,069
2,358
EPS (Basic)
0.42
0.43
0.52
0.65
1.53
1.74
Basic Shares Outstanding
1,010
1,058
1,257
1,286
1,352
1,354
EPS (Diluted)
0.41
0.43
0.52
0.65
1.53
1.74
Diluted Shares Outstanding
1,010
1,058
1,257
1,286
1,352
1,354
EBITDA
1,024
1,109
1,346
1,860
2,097
2,373
Other Operating Expense
63
75
97
18
6
8
Non-Operating Interest Income
19
29
31
61
79
83
Minority Interest Expense
183
184
199
248
250
397

About Humanwell Healthcare

View Profile
Address
No. 666 Gaoxin Avenue
Wuhan Hubei 430075
China
Employees -
Website http://www.humanwell.com.cn
Updated 07/08/2019
Humanwell Healthcare (Group) Co., Ltd. engages in the research and development, production, and sale of medical products. It focuses on chemical preparations, chemical raw materials, Chinese medicine, and biological agents. Its business segment covers pharmaceutical manufacturing, medical service, distribution, and global presence or international market.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.